Agiliti (AGTI) Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agiliti in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AGTI shares.
View AGTI analyst ratings or view top-rated stocks.

6 Wall Street analysts have issued twelve-month price objectives for Agiliti's stock. Their AGTI share price forecasts range from $18.00 to $23.00. On average, they predict the company's stock price to reach $19.86 in the next year. This suggests a possible upside of 10.9% from the stock's current price.
View analysts price targets for AGTI or view top-rated stocks among Wall Street analysts.

Agiliti's stock was trading at $16.31 at the beginning of the year. Since then, AGTI shares have increased by 9.7% and is now trading at $17.90.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AGTI earnings forecast.

Agiliti, Inc. (NYSE:AGTI) announced its earnings results on Tuesday, May, 9th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. The firm had revenue of $299.90 million for the quarter, compared to the consensus estimate of $288.44 million. Agiliti had a trailing twelve-month return on equity of 9.21% and a net margin of 1.18%. The company's quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.27 earnings per share.

ETFs with the largest weight of Agiliti (NYSE:AGTI) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Syntax Stratified SmallCap ETF (SSLY), First Trust Small Cap Growth AlphaDEX Fund (FYC), iShares U.S. Healthcare Providers ETF (IHF),

Agiliti updated its FY23 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of $0.65-$0.70 for the period, compared to the consensus earnings per share estimate of $0.68. The company issued revenue guidance of $1.16-$1.19 billion, compared to the consensus revenue estimate of $1.18 billion.

(AGTI) raised $500 million in an initial public offering on Friday, April 23rd 2021. The company issued 26,300,000 shares at $18.00-$20.00 per share. BofA Securities, Goldman Sachs, Morgan Stanley, BMO Capital Markets, Citigroup, Jefferies and UBS Investment Bank served as the underwriters for the IPO and KeyBanc Capital Markets, Raymond James, MUFG, SMBC Nikko, Mischler Financial Group and Siebert Williams Shank were co-managers.

Agiliti trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGTI."

Agiliti's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.28%), JPMorgan Chase & Co. (3.65%), Fred Alger Management LLC (2.22%), Thrivent Financial for Lutherans (1.79%), State Street Corp (0.84%) and Dimensional Fund Advisors LP (0.62%). Insiders that own company stock include Bettyann Bird, Gary L Gottlieb, James B Pekarek, John L Workman, Lee M Neumann, Matthew E Mccabe, Robert L Creviston, Scott A Christensen and Thomas J Leonard.
View institutional ownership trends.

Shares of AGTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGTI stock can currently be purchased for approximately $17.90.

Agiliti (NYSE:AGTI) has a market capitalization of $2.41 billion and generates $1.12 billion in revenue each year. The company earns $30.21 million in net income (profit) each year or $0.09 on an earnings per share basis.

The company employs 5,500 workers across the globe.

The official website for the company is www.agilitihealth.com. The company can be reached via phone at (952) 893-3200 or via email at ir@agilitihealth.com.